Research use only · Lyophilised material · Not a medicine · Not for human or veterinary use · Disclaimer

Comparison · not a ranking

LL-37 compared with Thymosin alpha-1

LL-37 and Thymosin alpha-1 are separate catalogue items. They are not interchangeable.A CoA for every lot; each vial carries a printed lot number that matches it. Request yours and we email it within 2 hours. Research use only. Not a medicine.

Last verified 9 Nov 2026. UK prices checked daily.

LL-37 and Thymosin alpha-1 are not the same material. LL-37 is a 37-residue peptide, while Thymosin alpha-1 is a 28-residue peptide. LL-37: C205H340N60O53, 4493.0 g/mol, CAS 154947-66-7. Thymosin alpha-1: C129H215N33O55, 3108.3 g/mol, CAS 62304-98-7. By sequence, LL-37 is LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES and Thymosin alpha-1 is Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN. In short, their molecular weights differ by about 1384.7 g/mol; their sequences differ in length (37 versus 28 residues). Each has its own reference record, which lists the source for every figure above. Sable Peptides, a UK supplier operating since 2019, lists both as lyophilised research material; every vial carries a lot number and a certificate of analysis exists for every lot — request yours at /coa-request and we email it within 2 hours. This intro compares identity only and ranks neither compound. Research use only. Not a medicine. Not for human or veterinary use.

Sources: pubchem.ncbi.nlm.nih.gov · pubchem.ncbi.nlm.nih.gov

/ref/ll-37 · /ref/thymosin-alpha-1

LL-37 and Thymosin alpha-1 are two records in the Sable Peptides catalogue at https://www.sablepeptides.co.uk/versus/ll-37/thymosin-alpha-1. These prices are both Sable catalogue prices. They are not a comparison with another shop. This page does not rank either compound. Each page shows the catalogue price. A market comparison appears only when an exact, current, approved listing for that size is on record. Only a row with the same amount is a like-for-like price.

Research use only. Not a medicine. Not for human or veterinary use. Disclaimer

Same amount, both catalogue prices. Not a comparison with another seller.
AmountLL-37Thymosin alpha-1
5 mg£23.99£18.95
10 mg£34.99£27.00

Reference facts

FactLL-37Thymosin alpha-1
Molecular weight4493.0 g/mol3108.3 g/mol
Molecular formulaC205H340N60O53C129H215N33O55
CAS number154947-66-762304-98-7
Compound classpeptidepeptide

Sources: pubchem.ncbi.nlm.nih.gov, pubchem.ncbi.nlm.nih.gov Verified 2026-11-09

Category
LL-37Repair
Thymosin alpha-1Repair
Research use only
LL-37Yes
Thymosin alpha-1Yes
Vials
LL-372
Thymosin alpha-12
Record
LL-37ll-37
Thymosin alpha-1thymosin-alpha-1

LL-37 · Thymosin alpha-1

Questions this page answers

How does LL-37 compare with Thymosin alpha-1?
Same vial amounts are shown side by side with each catalogue price. Different amounts are not treated as the same price. No effect is compared, and another seller is not compared.
Which is better?
This page does not say. It does not rank safety, strength, or effect.
What is the lowest catalogue price per mg for LL-37 and Thymosin alpha-1?
LL-37: £3.50/mg on the 10 mg vial (£34.99). Thymosin alpha-1: £2.70/mg on the 10 mg vial (£27.00). Different compounds; this is a catalogue price fact, not a ranking.
How many vial sizes are listed for each?
LL-37: 5 mg, 10 mg. Thymosin alpha-1: 5 mg, 10 mg.

Both compounds

Related research

In-depth comparison

Sable research note. Updated 2026-10-10. Research use only.

Short answer

LL-37 and Thymosin alpha-1 (thymalfasin) are different compounds. LL-37 is a human cathelicidin antimicrobial peptide; Thymosin alpha-1 (thymalfasin) is a N-acetylated thymic peptide. By PubChem's computed values, LL-37 (4493 g/mol) is about 1.4 times the mass of Thymosin alpha-1 (thymalfasin) (3108.3 g/mol). Sable lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.

At a glance

LL-37 Thymosin alpha-1 (thymalfasin)
Class human cathelicidin antimicrobial peptide N-acetylated thymic peptide
Formula (PubChem) C205H340N60O53 C129H215N33O55
Molecular weight (PubChem, g/mol) 4493 3108.3
PubChem CID 16198951 16130571
Sable form freeze-dried powder freeze-dried powder

Structure

LL-37 is a 37-residue amphipathic, helical peptide beginning Leu-Leu, cleaved from the human cathelicidin protein hCAP18. PubChem CID 16198951 lists the formula C205H340N60O53 and a computed molecular weight of 4493 g/mol (https://pubchem.ncbi.nlm.nih.gov/compound/16198951).

Thymosin alpha-1 (thymalfasin) is a 28-residue N-terminally acetylated peptide, originally isolated from thymus tissue. PubChem CID 16130571 lists the formula C129H215N33O55 and a computed molecular weight of 3108.3 g/mol (https://pubchem.ncbi.nlm.nih.gov/compound/16130571).

Both are peptides, so the meaningful structural differences are sequence, length and modifications rather than chemical category. Differences in residue count, terminal capping (acetylation or amidation), non-natural amino acids and lipid side chains all change molecular weight, solubility and how a compound behaves in an assay. Matching like with like at the structural level is the first step before any comparison of experimental results.

Molecular weight in context

On PubChem's computed figures, LL-37 is a large peptide (over 3,000 g/mol) and Thymosin alpha-1 (thymalfasin) is a large peptide (over 3,000 g/mol). The difference is 1,384.7 g/mol.

Molecular weight matters in practice for three reasons. First, one milligram of a lighter compound contains more molecules than one milligram of a heavier one, so equal milligram amounts are not equal molar amounts. Second, the expected mass is what identity testing checks against: mass spectrometry on a certificate of analysis should report a value consistent with the formula. Third, salt forms (for example acetate or TFA counter-ions) and metal complexes add mass that a free-base figure does not show, so a certificate may legitimately quote a slightly different value from a database entry.

Class and research context

LL-37: studied in innate-immunity and antimicrobial research.

Thymosin alpha-1 (thymalfasin): studied in immunology research; also the active substance of a licensed medicine in some countries (Sable does not sell that medicine).

These descriptions summarise how each compound is characterised in the published literature and in chemical databases. They are not claims about effects in people, and Sable gives no administration or medical-use information for either compound. Readers who need mechanism detail should go to the primary sources and the PubChem literature sections linked below.

How to compare them fairly

  • Compare identity first: formula, sequence and expected mass, then purity.
  • Compare amounts only at the same milligram size, remembering that equal milligrams are not equal moles.
  • Ask for the certificate of analysis for the specific batch. At Sable, every vial is released at ≥99% purity by HPLC with identity checked against the expected mass, and certificates are available for every lot.
  • Treat a search pairing as a navigation habit, not as evidence that two compounds do the same thing.

Sable listings

Vial sizes as listed on 2026-10-10. Each product page carries the current catalogue details.

LL-37 (compound guide: https://www.sablepeptides.co.uk/ll-37-uk): - LL-37 5 mg: https://www.sablepeptides.co.uk/product/ll-37-5mg - LL-37 10 mg: https://www.sablepeptides.co.uk/product/ll-37-10mg

Thymosin alpha-1 (thymalfasin) (compound guide: https://www.sablepeptides.co.uk/thymosin-alpha-1-uk): - Thymosin alpha-1 5 mg: https://www.sablepeptides.co.uk/product/thymosin-alpha-1-5mg - Thymosin alpha-1 10 mg: https://www.sablepeptides.co.uk/product/thymosin-alpha-1-10mg

Peptide vials contain freeze-dried powder only; bacteriostatic water is listed separately. Research use only. Not a medicine. Not for human or veterinary use.

Sources

  • PubChem, LL-37: https://pubchem.ncbi.nlm.nih.gov/compound/16198951
  • PubChem, Thymosin alpha-1 (thymalfasin): https://pubchem.ncbi.nlm.nih.gov/compound/16130571
  • Sable price index and methodology: https://www.sablepeptides.co.uk/pricing/methodology
  • Sable quality and certificate requests: https://www.sablepeptides.co.uk/quality

Comparison questions

What is the difference between LL-37 and Thymosin alpha-1 (thymalfasin)?

LL-37 and Thymosin alpha-1 (thymalfasin) are different compounds. LL-37 is a human cathelicidin antimicrobial peptide; Thymosin alpha-1 (thymalfasin) is a N-acetylated thymic peptide. By PubChem's computed values, LL-37 (4493 g/mol) is about 1.4 times the mass of Thymosin alpha-1 (thymalfasin) (3108.3 g/mol). Sable lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.

What are the molecular weights of LL-37 and Thymosin alpha-1 (thymalfasin)?

LL-37: 4493 g/mol (PubChem CID 16198951); Thymosin alpha-1 (thymalfasin): 3108.3 g/mol (PubChem CID 16130571).

Are these sold for use in people?

No. Both are laboratory research material only: not medicines, and not for use in people or animals. No administration or medical-use information is provided.

LL-37 and Thymosin alpha-1 are different research compounds, compared here by vial sizes, price per mg and published identifiers. Sable Peptides sells LL-37 from £23.99 and Thymosin alpha-1 from £18.95. Every lot has an HPLC and mass-spectrometry Certificate of Analysis, emailed within 2 hours of a request.

Updated